+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Anti-Infective Drugs Global Market Report 2021: COVID-19 Implications and Growth to 2030

  • ID: 5292714
  • Report
  • February 2021
  • Region: Global
  • The Business Research Company

FEATURED COMPANIES

  • Gilead
  • GlaxosmithKline
  • Johnson & Johnson
  • Merck & Co
Anti-Infective Drugs Global Market Report 2021: COVID-19 Implications and Growth to 2030 covers this critical market and the impact on it from the COVID-19 virus. It provides strategists, marketers and senior management with the critical information they need to assess the increasing demand for anti-infective drugs which play a critical role in the treatment of patients with COVID-19.



Anti-Infective drugs help cure patients suffering from viral diseases including COVID-19.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market is experiencing rapid growth due to the coronavirus and how it is likely to stabilize as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Description:

Where is the largest and fastest growing market for the anti-infective drugs market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Anti-Infective Drugs Market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider anti-infective drugs market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The anti-infective drugs market section of the report gives context. It compares the anti-infective drugs market with other segments of the anti-infective drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, anti-infective drugs indicators comparison.
Scope

Markets Covered:
1) By Type: Antibiotics; Antivirals; Antifungals; Others (Anthelminthic, Antiprotozoal)
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/Drug Stores; Others
3) By Route Of Administration: Oral; Parenteral; Others
4) By Drug Classification: Branded Drugs; Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Companies Mentioned: Gilead; Merck & Co; GlaxosmithKline; Bristol-Myers Squibb Company; Johnson & Johnson

Metrics Covered: Number of Enterprises; Number of Employees

Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, anti-infective drugs indicators comparison.

Data segmentations: Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Frequently Asked Questions about the Global Anti-Infective Drugs Market

What is the estimated value of the Global Anti-Infective Drugs Market?

The Global Anti-Infective Drugs Market was estimated to be valued at €116.40 billion in 2021.

What is the growth rate of the Global Anti-Infective Drugs Market?

The growth rate of the Global Anti-Infective Drugs Market is 8.0%, with an estimated value of €158.30 billion by 2025.

What is the forecasted size of the Global Anti-Infective Drugs Market?

The Global Anti-Infective Drugs Market is estimated to be worth €158.30 billion by 2025.

Who are the key companies in the Global Anti-Infective Drugs Market?

Key companies in the Global Anti-Infective Drugs Market include Gilead, Merck & Co, GlaxosmithKline, Bristol and Johnson & Johnson.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Gilead
  • GlaxosmithKline
  • Johnson & Johnson
  • Merck & Co
1. Executive Summary

2. Report Structure

3. Anti-Infective Drugs Market Characteristics
3.1. Market Definition
3.2. Key Segmentations

4. Anti-Infective Drugs Market Product Analysis
4.1. Leading Products/ Services
4.2. Key Features and Differentiators
4.3. Development Products

5. Anti-Infective Drugs Market Supply Chain
5.1. Supply Chain
5.2. Distribution
5.3. End Customers

6. Anti-Infective Drugs Market Customer Information
6.1. Customer Preferences
6.2. End Use Market Size and Growth

7. Anti-Infective Drugs Market Trends and Strategies

8. Impact of COVID-19 on Anti-Infective Drugs

9. Anti-Infective Drugs Market Size and Growth
9.1. Market Size
9.2. Historic Market Growth, Value ($ Billion)
9.2.1. Drivers of the Market
9.2.2. Restraints on the Market
9.3. Forecast Market Growth, Value ($ Billion)
9.3.1. Drivers of the Market
9.3.2. Restraints on the Market

10. Anti-Infective Drugs Market Regional Analysis
10.1. Global Anti-Infective Drugs Market, 2020, by Region, Value ($ Billion)
10.2. Global Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Region
10.3. Global Anti-Infective Drugs Market, Growth and Market Share Comparison, by Region

11. Anti-Infective Drugs Market Segmentation
11.1. Global Anti-Infective Drugs Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Antibiotics
  • Antivirals
  • Antifungals
  • Others (Anthelminthic, Antiprotozoal)
11.2. Global Anti-Infective Drugs Market, Segmentation by Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies/ Drug Stores
  • Others
11.3. Global Anti-Infective Drugs Market, Segmentation by Route of Administration, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Oral
  • Parenteral
  • Others
11.4. Global Anti-Infective Drugs Market, Segmentation by Drug Classification, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Branded Drugs
  • Generic Drugs
11.5. Global Anti-Infective Drugs Market, Segmentation by Mode of Purchase, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Prescription-Based Drugs
  • Over-The-Counter Drugs
12. Anti-Infective Drugs Market Metrics
12.1. Anti-Infective Drugs Market Size, Percentage of GDP, 2015-2025, Global
12.2. Per Capita Average Anti-Infective Drugs Market Expenditure, 2015-2025, Global

13. Asia-Pacific Anti-Infective Drugs Market
13.1. Asia-Pacific Anti-Infective Drugs Market Overview
  • Region Information, Impact of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
13.2. Asia-Pacific, Anti-Infective Drugs Market, 2020, by Country, Value ($ Billion)
13.3. Asia-Pacific, Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
13.4. Asia-Pacific, Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
13.5. Asia-Pacific, Anti-Infective Drugs Market Metrics
13.5.1. Per Capita Average Anti-Infective Drugs Expenditure, 2015-2025, Asia-Pacific Countries
13.6. Asia-Pacific Anti-Infective Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7. Asia-Pacific Anti-Infective Drugs Market: Country Analysis
13.7.1. China Anti-Infective Drugs Market
13.7.1.1. China Anti-Infective Drugs Market Overview
13.7.1.2. China Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.1.3. China Anti-Infective Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.2. Australia Anti-Infective Drugs Market
13.7.2.1. Australia Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.2.2. Australia Anti-Infective Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.3. Hong Kong Anti-Infective Drugs Market
13.7.3.1. Hong Kong Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.4. India Anti-Infective Drugs Market
13.7.4.1. India Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.4.2. India Anti-Infective Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.5. Indonesia Anti-Infective Drugs Market
13.7.5.1. Indonesia Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.5.2. Indonesia Anti-Infective Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.6. Japan Anti-Infective Drugs Market
13.7.6.1. Japan Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.6.2. Japan Anti-Infective Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.7. Malaysia Anti-Infective Drugs Market
13.7.7.1. Malaysia Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.8. New Zealand Anti-Infective Drugs Market
13.7.8.1. New Zealand Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.9. Philippines Anti-Infective Drugs Market
13.7.9.1. Philippines Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.10. Singapore Anti-Infective Drugs Market
13.7.10.1. Singapore Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.11. South Korea Anti-Infective Drugs Market
13.7.11.1. South Korea Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.11.2. South Korea Anti-Infective Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.12. Thailand Anti-Infective Drugs Market
13.7.12.1. Thailand Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.13. Vietnam Anti-Infective Drugs Market
13.7.13.1. Vietnam Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

14. Western Europe Anti-Infective Drugs Market
14.1. Western Europe Anti-Infective Drugs Market Overview
14.2. Western Europe, Anti-Infective Drugs Market, 2020, by Country, Value ($ Billion)
14.3. Western Europe, Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
14.4. Western Europe, Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
14.5. Western Europe, Anti-Infective Drugs Market Metrics
14.5.1. Per Capita Average Anti-Infective Drugs Expenditure, 2015-2025, Western Europe Countries
14.6. Western Europe Anti-Infective Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7. Western Europe Anti-Infective Drugs Market: Country Analysis
14.7.1. Austria Anti-Infective Drugs Market
14.7.1.1. Austria Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.2. Belgium Anti-Infective Drugs Market
14.7.2.1. Belgium Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.3. Denmark Anti-Infective Drugs Market
14.7.3.1. Denmark Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.4. Finland Anti-Infective Drugs Market
14.7.4.1. Finland Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.5. France Anti-Infective Drugs Market
14.7.5.1. France Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.5.2. France Anti-Infective Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.6. Germany Anti-Infective Drugs Market
14.7.6.1. Germany Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.6.2. Germany Anti-Infective Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.7. Ireland Anti-Infective Drugs Market
14.7.7.1. Ireland Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.8. Italy Anti-Infective Drugs Market
14.7.8.1. Italy Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.9. Netherlands Anti-Infective Drugs Market
14.7.9.1. Netherlands Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.10. Norway Anti-Infective Drugs Market
14.7.10.1. Norway Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.11. Portugal Anti-Infective Drugs Market
14.7.11.1. Portugal Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.12. Spain Anti-Infective Drugs Market
14.7.12.1. Spain Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.13. Sweden Anti-Infective Drugs Market
14.7.13.1. Sweden Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.14. Switzerland Anti-Infective Drugs Market
14.7.14.1. Switzerland Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.15. UK Anti-Infective Drugs Market
14.7.15.1. UK Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.15.2. UK Anti-Infective Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

15. Eastern Europe Anti-Infective Drugs Market
15.1. Eastern Europe Anti-Infective Drugs Market Overview
15.2. Eastern Europe, Anti-Infective Drugs Market, 2020, by Country, Value ($ Billion)
15.3. Eastern Europe, Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
15.4. Eastern Europe, Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
15.5. Eastern Europe, Anti-Infective Drugs Market Metrics
15.5.1. Per Capita Average Anti-Infective Drugs Expenditure, 2015-2025, Eastern Europe Countries
15.6. Eastern Europe Anti-Infective Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7. Eastern Europe Anti-Infective Drugs Market: Country Analysis
15.7.1. Czech Republic Anti-Infective Drugs Market,
15.7.1.1. Czech Republic Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.2. Poland Anti-Infective Drugs Market
15.7.2.1. Poland Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.3. Romania Anti-Infective Drugs Market
15.7.3.1. Romania Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.4. Russia Anti-Infective Drugs Market
15.7.4.1. Russia Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.4.2. Russia Anti-Infective Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

16. North America Anti-Infective Drugs Market
16.1. North America Anti-Infective Drugs Market Overview
16.2. North America, Anti-Infective Drugs Market, 2020, by Country, Value ($ Billion)
16.3. North America, Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
16.4. North America, Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
16.5. North America, Anti-Infective Drugs Market Metrics
16.5.1. Per Capita Average Anti-Infective Drugs Expenditure, 2015-2025, North America Countries
16.6. North America Anti-Infective Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
16.7. North America Anti-Infective Drugs Market: Country Analysis
16.7.1. Canada Anti-Infective Drugs Market
16.7.1.1. Canada Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
16.7.2. Mexico Anti-Infective Drugs Market
16.7.2.1. Mexico Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
16.7.3. USA Anti-Infective Drugs Market
16.7.3.1. USA Anti-Infective Drugs Market Overview
16.7.3.2. USA Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
16.7.3.3. USA Anti-Infective Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

17. South America Anti-Infective Drugs Market
17.1. South America Anti-Infective Drugs Market Overview
17.2. South America, Anti-Infective Drugs Market, 2020, by Country, Value ($ Billion)
17.3. South America, Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
17.4. South America, Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
17.5. South America, Anti-Infective Drugs Market Metrics
17.5.1. Per Capita Average Anti-Infective Drugs Expenditure, 2015-2025, South America Countries
17.6. South America Anti-Infective Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7. South America Anti-Infective Drugs Market: Country Analysis
17.7.1. Argentina Anti-Infective Drugs Market
17.7.1.1. Argentina Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7.2. Brazil Anti-Infective Drugs Market
17.7.1.1. Brazil Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7.2.2. Brazil Anti-Infective Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7.3. Chile Anti-Infective Drugs Market
17.7.3.1. Chile Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7.4. Colombia Anti-Infective Drugs Market
17.7.4.1. Colombia Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7.5. Peru Anti-Infective Drugs Market
17.7.5.1. Peru Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7.6. Venezuela Anti-Infective Drugs Market
17.7.6.1. Venezuela Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

18. Middle East Anti-Infective Drugs Market
18.1. Middle East Anti-Infective Drugs Market Overview
18.2. Middle East, Anti-Infective Drugs Market, 2020, by Country, Value ($ Billion)
18.3. Middle East, Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
18.4. Middle East, Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
18.5. Middle East, Anti-Infective Drugs Market Metrics
18.5.1. Per Capita Average Anti-Infective Drugs Expenditure, 2015-2025, Middle East Countries
18.6. Middle East Anti-Infective Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
18.7. Middle East Anti-Infective Drugs Market: Country Analysis
18.7.1. Saudi Arabia Anti-Infective Drugs Market
18.7.1.1. Saudi Arabia Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
18.7.2. Israel Anti-Infective Drugs Market
18.7.2.1. Israel Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
18.7.3. Turkey Anti-Infective Drugs Market
18.7.3.1. Turkey Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
18.7.4. UAE Anti-Infective Drugs Market
18.7.4.1. UAE Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

19. Africa Anti-Infective Drugs Market
19.1. Africa Anti-Infective Drugs Market Overview
19.2. Africa, Anti-Infective Drugs Market, 2020, by Country, Value ($ Billion)
19.3. Africa, Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
19.4. Africa, Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
19.5. Africa, Anti-Infective Drugs Market Metrics
19.5.1. Per Capita Average Anti-Infective Drugs Expenditure, 2015-2025, Africa Countries
19.6. Africa Anti-Infective Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
19.7. Africa Anti-Infective Drugs Market: Country Analysis
19.7.1. Egypt Anti-Infective Drugs Market
19.7.1.1. Egypt Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
19.7.2. Nigeria Anti-Infective Drugs Market
19.7.2.1. Nigeria Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
19.7.3. South Africa Anti-Infective Drugs Market
19.7.3.1. South Africa Anti-Infective Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

20. Anti-Infective Drugs Market Competitive Landscape
20.1. Competitive Market Overview
20.2. Market Shares
20.3. Company Profiles
20.3.1. Gilead
20.3.1.1. Company Overview
20.3.1.2. Products and Services
20.3.1.3. Strategy
20.3.1.4. Financial Performance
20.3.2. Merck & Co
20.3.2.1. Company Overview
20.3.2.2. Products and Services
20.3.2.3. Strategy
20.3.2.4. Financial Performance
20.3.3. GlaxosmithKline
20.3.3.1. Company Overview
20.3.3.2. Products and Services
20.3.3.3. Strategy
20.3.3.4. Financial Performance
20.3.4. Bristol-Myers Squibb Company
20.3.4.1. Company Overview
20.3.4.2. Products and Services
20.3.4.3. Strategy
20.3.4.4. Financial Performance
20.3.5. Johnson & Johnson
20.3.5.1. Company Overview
20.3.5.2. Products and Services
20.3.5.3. Strategy
20.3.5.4. Financial Performance

21. Key Mergers and Acquisitions in the Anti-Infective Drugs Market

22. Market Background: Pharmaceutical Drugs Market
22.1. Pharmaceutical Drugs Market Characteristics
22.2. Pharmaceutical Drugs Market Historic and Forecast, 2015-2020, 2020-2025F, 2030F Growth, by Segment, Value ($ Billion), Global
22.3. Global Pharmaceutical Drugs Market, 2020, by Region, Value ($ Billion)
22.4. Global Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Region
22.5. Global Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Segmentation by Type, Value ($ Billion)

23. Recommendations
23.1. Global Anti-Infective Drugs Market in 2025 - Growth Countries
23.2. Global Anti-Infective Drugs Market in 2025 - Growth Segments
23.3. Global Anti-Infective Drugs Market in 2025 - Growth Strategies

24. Appendix
24.1. NAICS Definitions of Industry Covered in This Report
24.2. Abbreviations
24.3. Currencies
24.4. Research Inquiries
24.5. About the Publisher

25. Copyright and Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Gilead
  • GlaxosmithKline
  • Johnson & Johnson
  • Merck & Co
Major companies in the anti-infective drugs market include Gilead; Merck & Co; GlaxosmithKline; Bristol-Myers Squibb Company and Johnson & Johnson.

The global anti-infective drugs market is expected to decline from $132.16 billion in 2020 to $116.4 billion in 2021 at a compound annual growth rate (CAGR) of -11.9%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The market is expected to reach $158.29 billion in 2025 at a CAGR of 8%.

The anti-infective drugs market consists of sales of branded and generic anti-infective drugs and related services by entities (organizations, sole traders and partnerships) that manufacture branded or generic anti-infective drugs to treat microbial infections. The anti-infective drugs industry includes establishments that manufacture antibiotics to treat bacterial infections, anti-viral drugs to treat viral infections, anti-fungal drugs to treat fungal infections, anti-helminthic drugs to kill internal parasites, and antiprotozoal agents to treat protozoan infections. The anti-infective drugs market is segmented into antibiotics; antivirals; antifungals; and others (anthelminthic, antiprotozoal).

North America was the largest region in the global anti-infective drugs market, accounting for 50% of the market in 2020. Asia Pacific was the second largest region accounting for 20% of the global anti-infective drugs market. Africa was the smallest region in the global anti-infective drugs market.

Anti-infective drug manufacturers are investing in programs to develop drugs to treat drug resistant infections. Antimicrobial resistance is a serious concern to global public health as it resulted in long duration of illness, the requirement of additional tests and use of more expensive drugs. Antimicrobial resistance occurs when microorganisms such as bacteria, viruses, parasites and fungi change and adapted to drugs when they are exposed to antimicrobial drugs such as antibiotics, antivirals, antifungals, anthelmintics and others. According to World Health Organization (WHO), globally 4, 80,000 people are being affected by multi-drug resistant TB each year and drug resistance is starting to complicate the treatment of malaria and HIV as well. Companies are investing in developing the new drug candidates to treat drug-resistant infections. For instance, in 2018, plazomicin was approved by the US Food and Drug Administration (FDA) for the treatment of complicated, drug-resistant urinary tract infections.

The anti-infective drugs market is expected to be restrained by the increasing number of antimicrobial resistance cases due to growing ineffectiveness of conventional anti-infective drugs such as penicillin. Antimicrobial resistance is the final stage of the adaptation process of microorganisms such as bacteria to the environment developing the ability to resist the effects of anti-infective drugs. This is mainly caused by the overuse and misuse of anti-infective drugs such as antibiotics. The excessive use and misuse of anti-infective drugs increases the rate of the bacteria’s resistance, with an estimated 70% of bacteria ever discovered already being resistant to at least one anti-infective drug which was commonly used to treat them in the past. It is expected that deaths caused by antimicrobial resistance will rise from around 700,000 deaths in 2017 to 10 million deaths by 2050. Increasing incidences of bacteria’s resistance to anti-infective drugs are expected to limit the use of anti-infective drugs, affecting the market’s growth.

The anti-infective drugs market is expected to benefit from the latest developments in drug discovery procedures such as stem cells and organ-on-chip (OOC) technologies. OOCs are micro-engineered biometric systems that simulate the activities, mechanics and physiological responses of organ systems. Drug trial processes such as target identification, validation, and screening are being executed through OOC and stem cell technologies. These technologies are considerably reducing the drug discovery costs and generating reliable predictions on drug efficiency and human safety. Another area of development is physiology-simulation modelling, in which the integrated physiology of the human organism, in both health and disease, is simulated through a computer program. Eli Lilly and Pfizer have adopted Amazon’s Elastic Compute Cloud (EC2) platform to conduct simulation models in early stages of the drug discovery process that are operational within hours, whereas traditional models take weeks to conduct simulations. The wide adoption of these technologies is expected to drive the anti-infective drugs market in the forecast period.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Gilead
  • Merck & Co
  • GlaxosmithKline
  • Bristol-Myers Squibb Company
  • Johnson & Johnson
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll